Howard Franklin
Chief Tech/Sci/R&D Officer bei ASSERTIO HOLDINGS, INC.
Profil
Howard J.
Franklin is currently a Senior Vice President-Medical at Assertio Holdings, Inc. Prior to this, he worked as the Chief Medical Officer at Salix Pharmaceuticals Ltd.
from 2018 to 2022.
He also held the position of Chief Medical Officer at Finch Therapeutics Group, Inc. Dr. Franklin has an MBA from LaSalle University, an undergraduate degree from Lehigh University, and a doctorate from Drexel University College of Medicine.
Aktive Positionen von Howard Franklin
Unternehmen | Position | Beginn |
---|---|---|
ASSERTIO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06.03.2023 |
Ehemalige bekannte Positionen von Howard Franklin
Unternehmen | Position | Ende |
---|---|---|
SALIX PHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 01.03.2022 |
FINCH THERAPEUTICS GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Howard Franklin
LaSalle University | Masters Business Admin |
Lehigh University | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
FINCH THERAPEUTICS GROUP, INC. | Health Services |
ASSERTIO HOLDINGS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |